Tessa Therapeutics Doses First Patient in Phase 1b Clinical Trial Investigating TT11 in Combination with Nivolumab for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)
Phase 1b clinical trial (ACTION) designed to evaluate TT11 as a potential second-line therapy TT11,…